The Netherlands: In the midst of change

  At the World Pharma Pricing & Market Access Congress 2014 conference, Dr Martin van der Graaff, Secretary, Reimbursement Committee, CVZ gave the presentation: “The Netherlands: In the mi(d)st of change” Download and learn: Organisational change in CVZ End of an era: Policy rules and outcomes research First results and experiences with CED Preliminary criteria for prioritizing inpatient drugs Priorities Are …

observational research, payer, development, value, outcomes research, evidence europe

How can observational research be used to improve value development?

  At Evidence EU 2014, Clément François, Global Outcomes Research, Lundbeck gave a presentation on “Meeting payers’ needs: How can observational research be used to improve value development?” This presentation discusses the use of observational data through the different phases of development, as well as the different data sources for different objectives-from small dataset to large automated health care database. …

Guest post: How often is PRO data being used in health technology assessments?

      *This post was originally posted on the Context Matters blog* Context Matters will be exhibiting at Health Technology Assessment World Europe this December in London.  Join us at the 6th annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical companies discuss the challenges in obtaining market access.   …